Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.13
+0.11 (1.16%)
At close: Jun 5, 2025, 4:00 PM
9.12
-0.01 (-0.05%)
After-hours: Jun 5, 2025, 4:00 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $793.99 million as of June 5, 2025. Its market cap has decreased by -4.27% in one year.
Market Cap
793.99M
Enterprise Value
486.22M
1-Year Change
-4.27%
Ranking
Category
Stock Price
$9.13
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $793.99M, an increase of 612.79%. That is a compound annual growth rate of 52.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 784.85M | 18.40% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.72B |
| Johnson & Johnson | 373.90B |
| AbbVie | 330.30B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 276.42B |
| Abbott Laboratories | 232.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |